News Release

International Wex Technologies Inc. and Angel Investments Ltd. Sign Letter of Intent to Pursue Sales and Distribution of Tetrodin (HT)

Date: 1998/12/18

International Wex Technologies Inc. ("IWT") and Angel Investments Ltd., of London, England ("AI") announces that the two companies have signed a letter of intent that outlines the terms for the sales and distribution of the patented product Tetrodin(HT) in Mexico. The exclusive distribution right requested by AI will require AI to immediately undertake the opening of clinics in Mexico for the treatment of drug addiction. Under the anticipated agreement, IWT would be supplying Tetrodin (HT) to AI as the exclusive distributor in Mexico. Further details were not disclosed.

IWT has developed a patented new product named Tetrodin (HT). Tetrodin (HT) is a non-narcotic pharmaceutical that has proven to be a safe and effective treatment for all opiate (heroin, opium, morphine, methadone, etc.) addictions. Tetrodin (HT) functions very well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction.

For additional information on Tetrodin (HT), view the IWT website at http://www.wextech.ca or call Howard Milne at 604-683-8880 or 1-800-722-7549

Per: Donna Shum, Corporate Secretary